Listen to today’s podcast: https://www.youtube.com/channel/UC-nqwUyvLDEvs7bV985k-gQ
Stock Market Daily Podcast 12/25/2025
Welcome back to the Stock Market Daily Podcast. Today’s podcast episode was created from the following stories:
ETH, SOL, ADA slump as Bitcoin weakness lingers despite record stocks jump
Crypto markets softened as Bitcoin failed to hold above $90,000 and majors like Ether, Solana, and XRP fell, even while global equities hit new highs. CoinShares reported nearly $1 billion in outflows from digital asset products, signaling risk aversion and a possible shift toward safer assets.
Analysts note repeated failed rebounds and “measured selling” by larger players, suggesting a potential bear-phase mindset. The risk-off tone could extend to broader markets in the coming weeks, pressuring high-beta trades.
Why have multi-asset MFs beaten equity funds this year?
India’s multi-asset allocation funds outperformed pure equity funds, powered by sizable allocations to precious metals amid sharp rallies in gold and silver. With category returns averaging 16% over the past year, these funds benefited from dynamic allocation across equities, debt, and commodities.
They suit investors seeking automatic diversification and rebalancing across asset classes. Tax treatment varies by equity allocation, but the broader takeaway is clear: diversification helped cushion volatility and enhance returns.
2 Dividend Kings quietly beating the market this year
AbbVie and Johnson & Johnson delivered market-beating performance while maintaining decades-long dividend growth streaks. AbbVie’s expanding immunology and neuroscience franchises offset Humira declines, while J&J posted broad-based growth across oncology, immunology, and MedTech.
Both companies raised guidance and continue to support shareholder returns with solid cash flows and rising payouts. For income-focused investors, they underscore the staying power of high-quality dividend growers in choppy markets.
